Seres Therapeutics, Inc.MCRBNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank69
3Y CAGR-17.7%
5Y CAGR+4.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-17.7%/yr
vs +21.2%/yr prior
5Y CAGR
+4.9%/yr
Recent deceleration
Acceleration
-38.9pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $39.16M | -26.4% |
| 2024 | $53.18M | -31.4% |
| 2023 | $77.50M | +10.3% |
| 2022 | $70.26M | +1.4% |
| 2021 | $69.26M | +125.1% |
| 2020 | $30.77M | +24.4% |
| 2019 | $24.75M | -24.1% |
| 2018 | $32.60M | -4.2% |
| 2017 | $34.04M | +4.4% |
| 2016 | $32.62M | - |